We provide you with 20 years of free, institutional-grade data for NMRA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NMRA. Explore the full financial landscape of NMRA stock.
| Reported Date | CIK | Ticker | Type |
|---|
Neumora Therapeutics, Inc.(NASDAQ:NMRA) 
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.
Website: https://neumoratx.com/
Founded: 2019
IPO Price: $17 (Sep 15, 2023)
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends
The information provided in this report about NMRA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.